Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06382272

A Bionic Breast Project Using Neuroprosthesis to Reduce Chronic Pain After Mastectomy

This trial seeks to establish whether or not touch sensation can be restored to the breast via neural stimulation. Data will also be obtained to inform future feasibility (including safety), efficacy, and acceptability trials.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

University of Chicago Medicine Comprehensive Cancer Center

Chicago, Illinois, 60637, United States

Location status: Recruiting

Location contact

Bionic Breast Team

CONTACT

(773) 873-2011

Clinical Trials Intake

CONTACT

[email protected]

18557028222

Stacy Lindau

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years of age or older
  • Scheduled for bilateral mastectomy with two-stage (tissue expander) reconstruction at UCM
  • Bilateral mastectomy for unilateral in situ or T1to T2, clinically, N0 (no lymph node involvement) breast cancer or breast cancer risk reduction due to known elevated breast cancer risk. (Note - 19-34% of women choosing mastectomy for small unilateral breast cancer elect bilateral mastectomy.)40 We will enroll from this cohort.
  • Agrees to have breast tissue expander removed within 12-20 weeks of implantation.
  • Has access to a cell phone and willing to provide the research interviewer with the cell phone number
  • Agrees to receive text messages from the study
  • Able to speak and understand English or Spanish
  • Able to participate in the informed consent process

Exclusion criteria

  • Requires adjuvant chemotherapy
  • Single stage mastectomy and reconstruction procedure
  • Clinical evidence of bilateral breast cancer
  • Clinical evidence of lymph node involvement
  • Prior history of mastectomy or other major breast surgery
  • Prior history of radiation to the chest area (e.g., mantle radiation for Hodgkin's disease)
  • Prior history of injury (e.g., trauma, surgery, burn) that the participant perceives to have had an effect on the sensation of the breast
  • Pregnant or intending to become pregnant during the study period
  • Pacemaker, defibrillator or other implanted electrical stimulation device that may be affected by the implanted electrodes
  • Complex regional pain syndrome or other pain syndromes or a history of a neurologic condition like multiple sclerosis, degenerative neurological disease, cognitive impairment or dementia
  • Uncontrolled diabetes
  • History of poor wound healing or chronic skin ulcerations
  • History of uncontrolled infection or active infection at time of consent
  • Expectation that MRI will be required while the devices are implanted
  • Inability or unwillingness to follow verbal instructions and comply with study procedures
  • Untreated or poorly managed physical or mental health condition that may pose additional risk according to clinical judgment of the patient's breast surgeon or surgeons
  • Unwillingness to undergo psychological evaluation to determine study eligibility, if requested or required by surgeons or investigators

Treatment and study plan

Bionic Breast implant

Device

A small medical device will be temporarily implanted in one of the breasts at the time of the mastectomy. This device is capable of sending very small electrical currents to the nerves that can deliver sensory stimulation in response to touch and pressure applied to the breast

Primary outcomes

  1. Psychophysical tasks to assess stimulation-elicited sensation

    Time frame: 7 months after mastectomy+implantation and removal of device

    The purpose of the detection task is to determine the minimum pulse amplitude (PA) required to elicit a detectable percept for each C-FINE contact.

Secondary outcomes

  1. Maximum stimulation level

    Time frame: 7 months after mastectomy+implantation and removal of device

    To determine the maximum range of stimulation that elicits comfortable sensation.

  2. Amplitude discrimination task

    Time frame: 7 months after mastectomy+implantation and removal of device

    The purpose of this task is to determine the amount by which PA needs to be changed to evoke a reliably distinguishable percept for each C-FINE contact.

  3. Frequency discrimination task

    Time frame: 7 months after mastectomy+implantation and removal of device

    The purpose of this task is to determine the amount by which pulse frequency (PF) needs to change to evoke a reliably distinguishable percept for each C-FINE contact.

  4. Magnitude estimation

    Time frame: 7 months after mastectomy+implantation and removal of device

    The purpose of this task is to (further) characterize the relationship between PA/PF and sensory magnitude.

  5. Projected field mapping

    Time frame: 7 months after mastectomy+implantation and removal of device

    The purpose of this task is to map the location of percepts evoked by stimulation through each C-FINE contact.

Study contacts

Contact information is provided by the study sponsor or research team.

Clinical Trials Intake

CONTACT

[email protected]

18557028222

Sponsors and collaborators

Lead sponsor

University of Chicago

Other

Collaborators

  • National Cancer Institute (NCI)

Registry information

Official study title

Bionic Breast Project: A Neuroprosthesis to Restore Touch Sensation and Reduce Chronic Pain After Mastectomy

Important dates

Study start
2025
Primary completion
2028
Study completion
2028
First posted
Apr 24, 2024
Registry last updated
Apr 27, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.